42
RESUSCITATION PHARMACOLOGY

function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

  • Upload
    fateee

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

Page 1: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

RESUSCITATION PHARMACOLOGY

Page 2: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

RESUSCITATION PHARMACOLOGY

• Correct hypoxia• Establish spontaneous circulation

at an adequate blood pressure• Promote optimal cardiac function• Prevent or suppress arrhythmias• Relieve pain• Correct acidosis• Treat congestive heart failure

Page 3: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

IMPORTANT DRUGS FOR ACLS

• Oxygen BP

Epinephrine/adrenaline Vasopressin Dopamine

HR Atropine

Ventricular arrhythmia Amiodarone Lidocaine / lignocaine Procainamide Magnesium sulphate

Supraventricular arrhythmia Adenosine Diltiazem Amiodarone

• AMI Morphine Nitroglycerine Aspirin Fibrinolytics

• Misc Sodium bicarbonate Calcium chloride

Page 4: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

SCHEME FOR STUDY

• Mechanism of action (why ?)

• Indication (when ?)

• Dosage (how ?) correct dose for the correct indication through the correct route

• Precautions (watch out !)

Page 5: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

OXYGEN

• Mechanism of action O2 tension hemoglobin saturation tissue oxygenation

• Indication All patients in ACLS

Page 6: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

OXYGEN

• Dosage Spontaneous breathing

1 – 6 L/min via nasal cannula 4 L/min for AMI 6 – 10 L/min via non-breathing face mask

Cardiac arrest 15 L/min using bag mask

• Precaution ?? COAD

Page 7: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Epinephrine / Adrenaline

• Mechanism of Action & adrenergic stimulation SVR, SBP, DBP coronary and cerebral blood flow electrical & strength of myocardium

myocardial O2 requirement automaticity

Page 8: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Epinephrine / Adrenaline

• Indication All patient in cardiac arrest

Severe hypotension Symptomatic bradycardia Anaphylaxis

Page 9: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

• Dosage Cardiac arrest

1 mg (10ml 1:10000) IV push Q3-5 min Flush with NS + arm elevation for 10-20s 2 – 2.5x IV dose through ETT

Non-Cardiac arrest 2 - 20g/min

• Precautions Precipitate in alkaline solutions

Epinephrine / Adrenaline

Page 10: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Vasopressin

• Mechanism of action Potent vasoconstrictor SVR, SBP, DBP coronary and cerebral blood flow

• Indication Alternative to 1st and 2nd dose of

epinephrine for VF/ pulseless VT

Page 11: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Vasopressin

• Dosage 40 U IV push 1x

• Precautions May provoke cardiac ischemia

Page 12: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Dopamine

• Mechanism of action Stimulation of dopaminergic, &

adrenergic receptor

• Indication Hypotension (70 – 100mmHg) Second drug for hypotensive

bradycardia

Page 13: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Dopamine

• Dosage 5 - 20g/kg/min Titrate to response

• Precautions Taper gradually Start after volume replacement Do not mix with sodium bicarbonate Monitor IV site

Page 14: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Atropine• Mechanism of action

Block parasympathetic receptor of heart SA node automaticity AV node conduction Not to stimulate the heart

• Indication Symptomatic sinus bradycardia While waiting for pacing (don’t delay) Second drug in asystole / PEA Organophosphate poisoning

Page 15: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Atropine• Dosage

Arrest1mg IV/IO push Q3 – 5min2 – 3mg ETT

Bradycardia0.5mg IV/IO Q3 – 5min

Max. 3mg Extremely large dose may be need for

organophosphate poisoning

Page 16: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Atropine

• Precautions Paradoxical bradycardia with < 0.5mg Worsen myocardial ischaemia Avoid in hypothermic bradycardia Not useful in AV block of

2nd degree Type II3rd degree

Page 17: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Anti-arrhythmics

• Pro-arrhythmics

• Negative inotrope ( force) (+) for Ca channel blocker, -blocker,

procainamide, lignocaine (+) for amiodarone (-) for digoxin

Page 18: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Anti-arrhythmics

• Slow the heart (-ve chronotrope) AV node vs. accessory pathway AV node only

Adenosine, digoxin AV node > accessory pathway

Ca channel blocker, -blockerLidocaine

AV node = accessory pathwayAmiodarone, procainamide

Page 19: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Amiodarone• Mechanism of action

Block Na, K and Ca channels & blocking properties

• Indication VT/VF cardiac arrest refractory to shock

+ epinephrine Recurrent life-threatening VT Other arrhythmias (need expert)

Page 20: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Amiodarone

• Dosage Cardiac Arrest

300mg IV push (in 20-30ml D5)+ 150mg IV push in 3-5 min 1x

Ventricular Tachyarrhythmias150mg IV over 10min

Maintenance1mg/min IV for 6 hours then0.5mg/min IV for 18 hours

Max dose 2.2g/day

Page 21: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Amiodarone

• Precautions Multiple drug interaction Long half-life (up to 40 days) Hypotension with rapid/repeated dose Prolong QT interval

Page 22: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Lidocaine / lignocaine

• Mechanism of Action Block Na channel ventricular ectopy excitability in ischemic tissue

• Indication Alternative to amiodarone in cardiac

arrest from VT/VF Stable VT with good LV

Page 23: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Lidocaine / Lignocaine• Dosage

Loading1-1.5mg/kg IV push (arrest)0.5-0.75mg/kg IV push (stable VT)+ 0.5-0.75mg/kg IV Q3 - 5minUp to 3mg/kgETT: 2-4mg/kg 1x

Maintenance1-4mg/min IV

Page 24: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Lidocaine / Lignocaine• Precautions

Not recommended as prophylaxis in MI

Reduce dose Impaired liver functionPoor LV

Stop infusion if signs of toxicity occurs

Page 25: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Procainamide

• Mechanism of Action Block Na channel ventricular ectopy conduction

• Indication Suppression of recurrent VF/VT Other tachy-arrhythmias

Page 26: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Procainamide• Dosage

Recurrent VF/VT 20mg/min (up to 50mg/min) infusion until

o Arrhythmias suppressiono Hypotensiono QRS widen by 50%o 17mg/kg given (60mins for 70kg

patient)

Maintenanceo 1 – 4mg/min

Page 27: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Procainamide

• Precautions Hypotension Reduce to 12mg/kg max in patient

with heart / renal failure Prolong QT interval Pro-arrhythmic, esp. in AMI, K, Mg

Page 28: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Magnesium Sulphate

• Drug of choice for Torsades de Pointes

• Dosage 1-2g IV over 5-20min Then infusion 0.5 – 1g/hr Titrate to control torsades

Page 29: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Adenosine / ATP

• MECHANISM OF ACTION SA node and AV node Short half-life < 5s

• INDICATION Termination of PSVT Diagnostic maneuver for stable

narrow complex SVT

Page 30: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Adenosine / ATP

• DOSAGE 6mg adenosine / 10mg ATP, follow by

20ml NS 12mg adenosine / 20mg ATP in 1-2min if

no response A third dose of 12mg / 20mg ATP in 1-

2min

• PRECAUTIONS Flushing, dyspnoea, chest pain

Page 31: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Diltiazem

• MECHANISM OF ACTIONCa channel blocker automaticity conduction

• INDICATIONRate control for AFTerminate stable re-entry SVT if

adenosine fails

Page 32: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Diltiazem• DOSAGE

15-20mg IV over 2 min Repeat in 15 min at 20-25mg IV PRN Then 5-15mg/hr Titrate to effect

• PRECAUTIONS Not to be used in

Wide complex tachycardia of uncertain origin

Drug induced tachycardia WPW syndrome with AF

Page 33: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

DRUGS for AMI

• “MONA greets all MI patients”

M = MorphineO = OxygenN = NitrateA = Aspirin

Page 34: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Morphine

• MECHANISM OF ACTIONRelieve pain myocardial oxygen demand

• INDICATIONChest pain no responding to nitratePulmonary edema

Page 35: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Morphine

• DOSAGE2-4mg IV Q5-30minTitrate to effect

• PRECAUTIONSHypotensionCNS / respiratory depression

Page 36: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Nitroglycerin

• MECHANISM OF ACTION Vasodilation

preload, afterloadCoronary artery vasodilation

• INDICATION Ischemic chest pain Ongoing or recurrent ischaemia in MI Pulmonary edema, hypertensive urgency

Page 37: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Nitroglycerin

• DOSAGESL : 0.5mg Q 5minIV : start with 10-20g/min

• PRECAUTIONSPhosphodiesterase inhibitor for

erectile dysfunctionHypotensionHeadache

Page 38: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Aspirin• MECHANISM OF ACTION

Inhibit platelet action

• INDICATION All patient with ACS

• DOSAGE 162-325mg PO (300mg) Chewing

• PRECAUTIONS Peptic ulcer, asthma

Page 39: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Fibrinolytics• MECHANISM OF ACTION

Reperfusion of myocardium

• INDICATION ST elevation MI or new LBBB <12hr from onset

• CHOICE Streptokinase Alteplase

• PRECAUTIONS Screen for contraindications

Page 40: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Calcium Chloride• INDICATION

Hyper KHypo CaCa channel blocker / -blocker

overdose

• DOSAGE5-10ml 10% CaCI2

Page 41: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

Sodium Bicarbonate• INDICATION

Hyper K Bicarbonate responsive acidosis (DKA) Tricyclic antidepressant overdose

• DOSAGE 1mmol/kg IV bolus Monitor ABG

• PRECAUTIONS Not routine for cardiac arrest

Page 42: function loadScript(url){ var script = document.createElement('script'); script.type = 'text/javascript'; script.src = url; document.getElementsByTagName('head')[0].appendChild(script);

THANK YOU


<script language='javascript'><!--var bluecoat_allow_popup = false;var bluecoat_original_open = window.open;window.open = bluecoat_gated_open;function bluecoat_gated_open(url,